EN DE

New Nordic Healthbrands AB (NNH) Fair Value & Analysis

Consumer Defensive · SE · Market cap 75.6M SEK

NN New Nordic Healthbrands AB NNH · ST
Pricekr 19.40
Fair Valuekr 26.26
Upside+35.4%
Quality62/100
Watch New Nordic Healthbrands AB for free, get notified when fair value or trend changes. Watch for free
Healthy Growth
Thin margins · 0.5% net margin
Low debt · generates free cash flow
2.02% dividend yield
Mixed vs. peers (7/14)
Narrow moat 27/100
Evidence: High Range kr 16.87 – kr 34.72 Share as image

Fair value as of: Jul 17, 2026

From 24 valuation models · updated 24 days ago

Fair value updated Jul 17, 2026, revised from kr 26.34 to kr 26.26 (−0.3%) since Jun 25, 2026. Share price +56.5% over the past month.

A solid business, screening 35% undervalued on our models.

What matters now

  • Solid quality (62/100) at a price below fair value, the discount is the argument here, not the business quality.
  • A fairly wide model range (kr 16.87 to kr 34.72) leaves room in how you read the outcome.
Share this valuation: 𝕏 WhatsApp

Price vs Fair Value (5 years)

kr 102.73 kr 11.90 Fair Value kr 26.26 May 2021 Aug 2026

White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Jul 17, 2026.

How to read this chart

60‑month range kr 11.90 – kr 102.73 · fair‑value band kr 16.87 – kr 34.72 · the kr 19.40 price screens below the kr 26.26 fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). Dashed = 300-day average. As of Jul 17, 2026.

Full chart & analysis →

Which stocks are undervalued right now? Check free Discover now →

Analysis

New Nordic Healthbrands AB (NNH) currently trades at kr 19.40, while our model-based Fair Value estimate is kr 26.26, implying the stock looks roughly 35.4% undervalued today. The Quality Score stands at 62/100 (solid quality), in the Consumer Defensive sector. Bull case: trading below our estimate, it may offer upside if the fundamentals hold. Bear case: a low price can be a value trap when quality is weak or the data is thin (evidence: high), always confirm before acting.

Over the trailing twelve months, New Nordic Healthbrands AB generated revenue of 565M SEK at a net margin of 0.5%. Revenue declined 7.9% year over year. It earns a return on equity of 2.7%. Net debt stands at 19.3M SEK. Fundamentals as of Jul 17, 2026

Our scenario range runs from kr 16.87 (bear case) to kr 34.72 (bull case); at kr 19.40, the current price sits within that range. Bear and bull are the same models run on conservative and optimistic assumptions (margins, growth, valuation multiples), so a plausible valuation range, not a price target. The share trades about 30% below its 52-week high and 46% above its 52-week low, currently below its 200-day average. For context, the median of 10 Consumer Defensive peers we cover trades at -3% fair-value upside, at 35%, NNH screens cheaper than that median.

Fair Value models

Each model estimates fair value its own way; the Fair Value above is the evidence-weighted blend. Evidence (0–100) measures how completely this model’s inputs are available: well-fed models carry more weight in the blend. The spread across models is intentional, each one stresses a different value driver; dividend models, for instance, come out structurally low when payout is small.

Model Bear Bear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull Bull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target. Evidence
Highest evidence
Growth DCF kr 12.67 kr 16.47 kr 21.02 80
Residual Income kr 12.46 kr 12.80 kr 12.66 76
Rev-Margin DCF kr 18.80 kr 30.11 kr 43.40 74
All 24 models by family
DCF Models
FCF DCF kr 12.70 kr 17.18 kr 22.95 38
Owner Earnings kr 15.82 kr 21.65 kr 29.15 31
5Y Revenue Exit kr 18.80 kr 30.29 kr 45.27 39
5Y EBITDA Exit kr 20.76 kr 34.03 kr 49.81 41
5Y P/E Exit kr 17.28 kr 27.40 kr 38.21 38
10Y Revenue Exit kr 15.40 kr 24.23 kr 36.56 36
10Y EBITDA Exit kr 16.99 kr 26.47 kr 39.57 37
10Y P/E Exit kr 15.07 kr 22.50 kr 31.87 35
Earnings-Based
Graham-Dodd kr 9.00 kr 30.96 kr 41.57 54
Lynch FV kr 7.15 kr 10.21 kr 13.28 50
PEG = 1.0 kr 7.15 kr 10.21 kr 13.28 46
EPV kr 14.78 kr 16.28 kr 17.50 59
Multiples
P/E Multiple kr 20.83 kr 27.78 kr 34.72 63
P/S Multiple kr 16.87 kr 22.49 kr 28.11 58
P/B Multiple kr 16.87 kr 22.49 kr 28.11 55
EV/EBIT kr 33.47 kr 43.86 kr 54.25 53
EV/EBITDA kr 30.01 kr 39.25 kr 48.49 54
EV/Revenue kr 24.55 kr 34.08 kr 43.62 43
Asset-Based
NCAV (Graham) kr 8.35 kr 11.19 kr 16.70 50
Growth DCF
Growth DCF kr 12.67 kr 16.47 kr 21.02 80
Rev-Margin DCF kr 18.80 kr 30.11 kr 43.40 74
Economic Profit
Residual Income kr 12.46 kr 12.80 kr 12.66 76
ROIC Compounder kr 14.78 kr 16.28 kr 18.15 72
Growth Earnings
Growth-Adj P/E kr 17.86 kr 25.51 kr 33.16 68

Widest divergence: Multiples (kr 27.78) versus Earnings-Based (kr 10.21). Highest evidence: Growth DCF (80).

Notify me when NNH reaches fair value

Free. You confirm by email (double opt-in) and can unsubscribe anytime in one click.

Key figures & financial health

Revenue (TTM) 565M SEK
Revenue growth (YoY) -7.9%
Net margin 0.5%
Return on equity 2.7%
Free cash flow 7.6M SEK FY2025
P/E ratio 32.8
More key figures
Operating margin -1.1%
EPS (TTM) kr 0.4300
Dividend yield 1.8%
EPS growth (YoY) +5.9%
Net debt 19.3M SEK FY2025

Figures from reported company fundamentals · as of Jul 17, 2026. TTM = trailing twelve months.

Quality Score breakdown

Overall quality 62/100

Of which business quality 60 · Market factors (momentum, volatility) 35

Profitability 40
Margins and returns on capital today
Quality Growth 63
Are margins and returns improving?
Cashflow 42
Earnings quality: real cash, not paper profit
Fin. Strength 60
Balance sheet, leverage, solvency risk
Investment 100
Disciplined investing over empire-building
Low Volatility 29
Calm price path (market factor)
Momentum 44
Price trend over the last 3–12 months (market factor)
52W Momentum 27
Distance to the 52-week high (market factor)
Net Issuance 82
Buybacks instead of dilution

Non-valuation factor families (profitability, growth, cashflow, financial strength, momentum …), each academically grounded. Valuation itself sits in the Fair Value and is deliberately excluded here to avoid double-counting.

About the company

New Nordic Healthbrands AB (publ) manufactures and sells dietary supplements, herbal remedies, and related personal care products in the Nordic countries, rest of Europe, North America, and internationally.

Full company description

New Nordic Healthbrands AB (publ) manufactures and sells dietary supplements, herbal remedies, and related personal care products in the Nordic countries, rest of Europe, North America, and internationally. The company offers body care, dietary supplements, facial care, assortment, and natural magic trio products; hair volume series, dietary supplements, shampoo and conditioner, hair care, and range products; vitality products, such as vitamins and minerals, body, fish oil and omega-3, menopause, sleep and relaxation, men's health, and magnesium products; detox, digestion, and weight loss products. It sells its products under the NEW NORDIC brand through pharmacies, department stores, travel retailers, health stores, e-commerce, and direct to consumers. New Nordic Healthbrands AB (publ) was founded in 1990 and is headquartered in Malmö, Sweden.

Company description, as reported by the company or data provider.

Revenue & earnings trend

FY2021 – FY2025 · reported fiscal years

New Nordic Healthbrands AB reported revenue of kr 576M in FY2025 versus kr 515M in FY2021, a compound +2.9%/yr. Reported net income was kr 8.2M in FY2025, compounding −21.2%/yr from FY2021.

Growth Quality 64/100
Revenue growth appears healthy and is supported by profitability and cash-flow quality.
Latest Revenue (FY 2025)
576M SEK
Latest YoY
+4.7%
Avg. growth/yr (3Y) Measures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump.
+5.7%
Avg. growth/yr (5Y) Measures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump.
+5.1%
Avg. growth/yr (17Y) Measures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump.
+6.4%
Revenue +2.9%/yr
FY21 kr 515M
FY22 kr 488M
FY23 kr 534M
FY24 kr 550M
FY25 kr 576M
Net income −21.2%/yr
FY21 kr 21.3M
FY22 −kr 2.8M
FY23 −kr 6.2M
FY24 −kr 7.7M
FY25 kr 8.2M

Watch NNH: get an alert when its fair value changes →

Share or link this analysis
For bloggers & editors: embed code + live data

For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.

Cite: Fair Value Calculator (2026). "New Nordic Healthbrands AB Fair Value". https://www.fairvalue-calculator.com/stock/NNH

Peer Group

Packaged Foods · 649 stocks

How this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.

Quality Score 62 · Above median
Fair Value upside +35% · Above median
Return on equity (TTM) 3% · Below median
Return on assets 2% · Below median
Net margin (TTM) 0% · Below median
Operating margin (TTM) -1% · Bottom 25%
Revenue growth -8% · Bottom 25%
Dividend yield (TTM) 2.0% · Below median
Debt / equity 0.02× · Lower than median

Valuation Multiples vs Packaged Foods median · lower = cheaper

P/E (TTM) 28.4× · Pricier than 75% of peers
P/B 0.73× · Cheaper than median
P/S (TTM) 0.13× · Cheaper than 75% of peers
P/FCF 1.1× · Cheaper than median
EV/EBITDA 5.9× · Cheaper than median

Snowflake

Five quick dimensions, each 0 to 100: VALUE (fair-value potential), FUTURE (revenue growth), PAST (return on equity), HEALTH (low debt), DIVIDEND (yield). Green = this stock, grey = typical sector peer.

VALUE 81 · sector 28
FUTURE 0 · sector 20
PAST 11 · sector 27
HEALTH 99 · sector 96
DIVIDEND 40 · sector 47

Values & ESG

Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.

None of the checked exposures detected

ESG scores are not available for this stock yet. Values and ESG data are contextual and can differ between providers.

Similar stocks

10 more Packaged Foods stocks, each showing price versus our Fair Value estimate (as of Jul 17, 2026).

Stock Price Fair Value vs Fair Value
Nestlé India Limited NESTLEIND ₹1,427 ₹362.37 -75%
Britannia Industries Limited BRITANNIA ₹5,413 ₹1,870 -65%
Tata Consumer Products Limited TATACONSUM ₹1,089 ₹327.27 -70%
PT Indofood CBP Sukses Makmur Tbk ICBP 6,650 IDR 15,757 IDR +137%
Samyang Foods Co 003230 1,139,000 KRW 1,010,543 KRW -11%
Patanjali Foods Limited PATANJALI ₹413.80 ₹157.04 -62%
Vietnam Dairy Products Joint Stock Company VNM 58,500 VND 68,259 VND +17%
PT Mayora Indah Tbk, MYOR 1,750 IDR 2,699 IDR +54%
PT Cisarua Mountain Dairy Tbk CMRY 4,490 IDR 4,355 IDR -3%
Nongshim Co 004370 348,500 KRW 530,619 KRW +52%

Compare New Nordic Healthbrands AB with another stock

Price, fair value, quality and upside side by side.

Free, no sign-up

Explore undervalued stocks

More undervalued Consumer Defensive stocks →

All undervalued stocks TechnologyFinancial ServicesHealthcareConsumer CyclicalConsumer DefensiveCommunication ServicesIndustrialsEnergyBasic MaterialsReal EstateUtilities Deeply Undervalued StocksUndervalued Blue-Chip StocksUndervalued Small-Cap StocksUndervalued Dividend Stocks

Frequently asked questions

Is New Nordic Healthbrands AB (NNH) overvalued or undervalued?
As of Jul 17, 2026, our model estimates a fair value of kr 26.26 versus a price of kr 19.40, about +35% (undervalued).
What is the fair value of NNH?
Our model-based fair value for New Nordic Healthbrands AB is kr 26.26 (as of Jul 17, 2026), built from audited fundamentals. The current price is kr 19.40.
What is the quality score of NNH?
New Nordic Healthbrands AB has a Quality Score of 62/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the revenue of New Nordic Healthbrands AB (NNH)?
New Nordic Healthbrands AB reported trailing-twelve-month revenue of about 565M SEK (latest available figure, as of Jul 17, 2026).
What is the net profit margin of NNH?
The net profit margin of New Nordic Healthbrands AB is about 0.5%, meaning it keeps roughly 0.5% of revenue as net income. Based on the latest reported figures.
Does New Nordic Healthbrands AB pay a dividend?
New Nordic Healthbrands AB currently shows a dividend yield of about 1.79% relative to its recent price (as of Jul 17, 2026).

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data, nothing guessed.

14 days Pro free · no card

Track New Nordic Healthbrands AB and try Pro for 14 days

One email gets you 14 days of full Pro (review alerts, the 35,000+ stock screener, the diversification check) plus the monthly Top-25 report of the most undervalued quality stocks. No card, cancel anytime.

Zero risk: nothing is ever charged. After 14 days you decide whether to stay.